成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

DEMETHYLASTERRIQUINONE B1

DEMETHYLASTERRIQUINONE B1 Struktur
78860-34-1
CAS-Nr.
78860-34-1
Englisch Name:
DEMETHYLASTERRIQUINONE B1
Synonyma:
DAQ B1;DMAQ-B1;L-783,281;Demethylasterriquino;DEMETHYLASTERRIQUINONE B1;Demethylasterriquinone B-1,Demethylasterriquinone B1;2-[2-(1,1-DIMETHYLALLYL)-1H-INDOL-3-YL]-3,6-DIHYDROXY-5-[7-(3-METHYLBUT-2-ENYL)-1H-INDOL-3-YL][1,4]BENZOQUINONE;2,5-DIHYDROXY-3-[7-(3-METHYL-BUT-2-ENYL)-1H-INDOL-3-YL]-6-[2-(1,1-DIMETHYL-ALLYL)-1H-INDOL-3-YL]-[1,4]BENZOQUINONE;2-(2-(1,1-Dimethyl-2-propenyl)-1H-indol-3-yl)-3,6-dihydroxy-5-(7-(3-methyl-2-butenyl)-1H-indol-3-yl)-2,5-cyclohexadiene-;2-[2-(1,1 Dimethyl-2-propenyl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methyl-2-butenyl)-1H-indol-3-yl]-2,5-cyclohexadien-1,4-dione
CBNumber:
CB2320805
Summenformel:
C32H30N2O4
Molgewicht:
506.59
MOL-Datei:
78860-34-1.mol

DEMETHYLASTERRIQUINONE B1 Eigenschaften

Siedepunkt:
780.2±60.0 °C(Predicted)
Dichte
1.335±0.06 g/cm3(Predicted)
storage temp. 
Desiccate at -20°C
L?slichkeit
Soluble to 100 mM in DMSO
Aggregatzustand
Powder
pka
2.82±0.50(Predicted)

Sicherheit

DEMETHYLASTERRIQUINONE B1 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Demethylasterriquinone B1 (DMAQ B1) is a natural insulin mimic that activates insulin receptor tyrosine kinase (IRTK; EC50 = 6 μM). It less potently activates IGF1R and EGFR (EC50s = 100 μM for both). DMAQ B1 induces glucose uptake in adipocytes and skeletal muscle cells without activating proliferation. DMAQ B1 binds GAPDH in vitro.

Biologische Aktivit?t

Selective insulin receptor (IR) activator/mimetic (EC 50 values are 3-6 μ M for IRTK and 100 μ M for IGF1R and EGFR). Increases IR β subunit tyrosine phosphorylation and downstream activation of PI 3-kinase and Akt, but not ERK. Induces glucose uptake in adipocytes and skeletal muscle in vitro , without enhancing vascular proliferation. Binds GAPDH.

DEMETHYLASTERRIQUINONE B1 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


DEMETHYLASTERRIQUINONE B1 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 21)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
3bsc@sina.com China 15839 69
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8447 60
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58
Wuhan FengyaoTonghui Chemical Products Co., Ltd. 027-87466105 15377573527
2678564200@qq.com China 17987 58
BOC Sciences --
info@bocsci.com USA 0 65
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11218 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912
order@med-bio.cn China 8140 58
Shanghai Universal Biotech Co.,Ltd 13774214275
zhouzz@univ-bio.com China 24996 58

78860-34-1()Verwandte Suche:


  • 2,5-DIHYDROXY-3-[7-(3-METHYL-BUT-2-ENYL)-1H-INDOL-3-YL]-6-[2-(1,1-DIMETHYL-ALLYL)-1H-INDOL-3-YL]-[1,4]BENZOQUINONE
  • 2-[2-(1,1-DIMETHYL-2-PROPENYL)-1H-INDOL-3-YL]-3,6-DIHYDROXY-5-[7-(3-METHYL-2-BUTENYL)-1H-INDOL-3-YL]-2,5-CYCLOHEXADIENE-1,4-DIONE
  • 2-[2-(1,1-DIMETHYLALLYL)-1H-INDOL-3-YL]-3,6-DIHYDROXY-5-[7-(3-METHYLBUT-2-ENYL)-1H-INDOL-3-YL][1,4]BENZOQUINONE
  • DAQ B1
  • DEMETHYLASTERRIQUINONE B1
  • DMAQ-B1
  • L-783,281
  • 2-(2-(1,1-Dimethyl-2-propenyl)-1H-indol-3-yl)-3,6-dihydroxy-5-(7-(3-methyl-2-butenyl)-1H-indol-3-yl)-2,5-cyclohexadiene-
  • 2-[2-(1,1 Dimethyl-2-propenyl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methyl-2-butenyl)-1H-indol-3-yl]-2,5-cyclohexadien-1,4-dione
  • Demethylasterriquino
  • 2,5-Cyclohexadiene-1,4-dione, 2-[2-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methyl-2-buten-1-yl)-1H-indol-3-yl]-
  • Demethylasterriquinone B-1,Demethylasterriquinone B1
  • 78860-34-1
  • Protein Kinase
Copyright 2019 ? ChemicalBook. All rights reserved